Savara (SVRA) Accumulated Depreciation (2011 - 2025)
Savara (SVRA) reported Accumulated Depreciation of $2.3 million for Q4 2025, up 7.91% year-over-year from $2.2 million in Q4 2024, and up 7.91% quarter-over-quarter from $2.2 million in Q4 2024.
Savara (SVRA) Accumulated Depreciation (2011 - 2025) Analysis & Trends
Savara (SVRA) has 15 years of Accumulated Depreciation data on file, last reported at $2.3 million in Q4 2025.
- Accumulated Depreciation for Q4 2025 came in at $2.3 million, up 7.91% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.3 million (up 7.91% YoY), and the FY2025 annual result was $2.3 million, up 7.91% from the prior year.
- Accumulated Depreciation improved to $2.3 million in Q4 2025 per SVRA's latest filing, from $2.2 million in the prior quarter.
- Over five years, Accumulated Depreciation peaked at $2.3 million in Q4 2025 and troughed at $1.9 million in Q4 2022.
- A 5-year average of $2.1 million and a median of $2.1 million in 2021 frame the typical range for Accumulated Depreciation.
- The sharpest annual moves came in 2022 and 2025: Accumulated Depreciation slipped 7.5% in 2022, then advanced 7.91% in 2025.
- A 5-year view of Accumulated Depreciation shows it stood at $2.1 million in 2021, then fell by 7.5% to $1.9 million in 2022, then grew by 4.63% to $2.0 million in 2023, then gained by 7.46% to $2.2 million in 2024, then gained by 7.91% to $2.3 million in 2025.
- Business Quant data shows SVRA's Accumulated Depreciation at $2.3 million in Q4 2025, $2.2 million in Q4 2024, and $2.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Savara | 1.39 Bn | 1.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.33 Mn |
| Dec 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 2.01 Mn |
| Dec 31, 2022 | 1.92 Mn |
| Dec 31, 2021 | 2.08 Mn |
| Dec 31, 2020 | 1.97 Mn |
| Dec 31, 2019 | 1.67 Mn |
| Dec 31, 2018 | 1.37 Mn |
| Dec 31, 2017 | 851,000.00 |
| Dec 31, 2016 | 504,000.00 |
| Dec 31, 2015 | 339,000.00 |
| Dec 31, 2014 | 344,000.00 |
| Dec 31, 2013 | 262,000.00 |
| Dec 31, 2012 | 320,545.00 |
| Dec 31, 2011 | 274,187.00 |